Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
9 hedge funds and large institutions have $468K invested in Yield10 Bioscience, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
10% less funds holding
Funds holding: 10 → 9 (-1)
49% less capital invested
Capital invested by funds: $925K → $468K (-$457K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$1.59K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$18K |
| 2 |
Renaissance Technologies
New York
|
-$7.14K |
| 3 |
Morgan Stanley
New York
|
-$2.38K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $236K | -$7.14K | -9 | -2% |
|
|
BC
2
Birchview Capital
Burlington,
Vermont
| $62K | – | – | – |
|
|
CC
3
Cannell & Co
New York
| $59K | – | – | – |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $52K | – | – | – |
|
5
Geode Capital Management
Boston,
Massachusetts
| $29K | – | – | – |
|
|
GC
6
GMT Capital
Atlanta,
Georgia
| $17K | – | – | – |
|
7
BlackRock
New York
| $7K | – | – | – |
|
|
HDIM
8
Hanson & Doremus Investment Management
Burlington,
Vermont
| $5K | – | – | – |
|
|
9
Victory Capital Management
San Antonio,
Texas
| $1K | +$1.59K | +2 | New |
|
|
VF
10
Virtu Financial
New York
| – | -$18K | -19 | Closed |
|
|
11
Morgan Stanley
New York
| – | -$2.38K | -3 | Closed |
|
YTEN Hedge Fund Activity: Q3 2019 in Review
9 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q3 2019, worth a combined $468K — down 49% from $925K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of YTEN and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was Victory Capital Management, opening a new position worth an estimated $1.59K. The largest seller was Virtu Financial, exiting entirely with an estimated $18K sold.
- 9 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q3 2019, down from 10 in Q2 2019.
- Funds reported $468K of Yield10 Bioscience, Inc. Common Stock stock for Q3 2019, down 49% quarter-over-quarter.
- 1 fund opened new Yield10 Bioscience, Inc. Common Stock positions in Q3 2019 and 2 closed out, a net change of -1 holder.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q3 2019 was Victory Capital Management, an estimated $1.59K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q3 2019 was Virtu Financial, an estimated $18K sold.
Based on aggregated 13F filings for Q3 2019.